These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31669588)

  • 1. IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-κB, inhibited by methoxyluteolin.
    Bawazeer MA; Theoharides TC
    Eur J Pharmacol; 2019 Dec; 865():172760. PubMed ID: 31669588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells.
    Patel AB; Theoharides TC
    J Pharmacol Exp Ther; 2017 Jun; 361(3):462-471. PubMed ID: 28404689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.
    Weng Z; Patel AB; Panagiotidou S; Theoharides TC
    J Allergy Clin Immunol; 2015 Apr; 135(4):1044-1052.e5. PubMed ID: 25498791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2.
    Franke K; Wang Z; Zuberbier T; Babina M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling.
    Li W; Yin N; Tao W; Wang Q; Fan H; Wang Z
    Int Immunopharmacol; 2019 Jan; 66():82-90. PubMed ID: 30445310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.
    Taracanova A; Tsilioni I; Conti P; Norwitz ER; Leeman SE; Theoharides TC
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9381-E9390. PubMed ID: 30232261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized low-density lipoprotein induces inflammatory responses in cultured human mast cells via Toll-like receptor 4.
    Meng Z; Yan C; Deng Q; Dong X; Duan ZM; Gao DF; Niu XL
    Cell Physiol Biochem; 2013; 31(6):842-53. PubMed ID: 23816956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes.
    Wong CK; Li PW; Lam CW
    Immunol Lett; 2007 Oct; 112(2):82-91. PubMed ID: 17719653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells.
    Wuyts WA; Vanaudenaerde BM; Dupont LJ; Demedts MG; Verleden GM
    Respir Med; 2003 Jul; 97(7):811-7. PubMed ID: 12854631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-alpha: roles of ERK, p38 MAPK, and NF-kappaB.
    Wong CK; Tsang CM; Ip WK; Lam CW
    Allergy; 2006 Mar; 61(3):289-97. PubMed ID: 16436136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-beta.
    Kim MO; Suh HS; Brosnan CF; Lee SC
    J Neurochem; 2004 Jul; 90(2):297-308. PubMed ID: 15228586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeic acid phenethyl ester promotes anti-inflammatory effects by inhibiting MAPK and NF-κB signaling in activated HMC-1 human mast cells.
    Cho MS; Park WS; Jung WK; Qian ZJ; Lee DS; Choi JS; Lee DY; Park SG; Seo SK; Kim HJ; Won JY; Yu BC; Choi IW
    Pharm Biol; 2014 Jul; 52(7):926-32. PubMed ID: 24920235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Allergic and Anti-Inflammatory Effects of Kuwanon G and Morusin on MC/9 Mast Cells and HaCaT Keratinocytes.
    Jin SE; Ha H; Shin HK; Seo CS
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30642008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.
    Taracanova A; Alevizos M; Karagkouni A; Weng Z; Norwitz E; Conti P; Leeman SE; Theoharides TC
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E4002-E4009. PubMed ID: 28461492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antimicrobial peptide with angiogenic properties, AG-30/5C, activates human mast cells through the MAPK and NF-κB pathways.
    Kanazawa K; Okumura K; Ogawa H; Niyonsaba F
    Immunol Res; 2016 Apr; 64(2):594-603. PubMed ID: 26663017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salicylideneamino-2-thiophenol inhibits inflammatory mediator genes (RANTES, MCP-1, IL-8 and HIF-1alpha) expression induced by tert-butyl hydroperoxide via MAPK pathways in rat peritoneal macrophages.
    Chung J; Lee HS; Chung HY; Yoon TR; Kim HK
    Biotechnol Lett; 2008 Sep; 30(9):1553-8. PubMed ID: 18478184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase.
    Hung CC; Chang CT; Tian YC; Wu MS; Yu CC; Pan MJ; Vandewalle A; Yang CW
    Nephrol Dial Transplant; 2006 Apr; 21(4):898-910. PubMed ID: 16339163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tonggyu-tang, a traditional Korean medicine, suppresses pro-inflammatory cytokine production through inhibition of MAPK and NF-κB activation in human mast cells and keratinocytes.
    Kim HI; Hong SH; Ku JM; Kang S; Kim TY; Shin YC; Ko SG
    BMC Complement Altern Med; 2017 Mar; 17(1):186. PubMed ID: 28359265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin suppresses IL-31 production in IL-33-stimulated mast cells through MAPK and NF-κB signaling pathways.
    Che DN; Shin JY; Kang HJ; Cho BO; Kim YS; Jang SI
    Int Immunopharmacol; 2020 Jun; 83():106403. PubMed ID: 32197229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.